Patent ID: 9610292
Date: 2017-04-04
CPC Classifications: A61K,A61P

Claim:
1. A method of treatment of a disease characterized by AR expression selected from endometrial carcinoma, cervix carcinoma, epithelial ovarian carcinoma, uterine carcinoma, and fallopian carcinoma, the method comprising steps of: (a) providing 4,17β-dihydroxyandrost-4-ene-3-one, a salt thereof: or an ester thereof in an amount effective for such treatment; and (b) administering to females in need of such treatment the effective amount of 4,17β-dihydroxyandrost-4-ene-3-one, a salt thereof, or an ester thereof, wherein 4,17β-dihydroxyandrost-4-ene-3-one, a salt thereof, or an ester thereof is an androgen receptor specific compound that binds to an androgen receptor.